首页> 美国卫生研究院文献>Clinical Case Reports >Severe coronavirus disease 2019 (COVID‐19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series

【2h】

Severe coronavirus disease 2019 (COVID‐19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series

机译：2019年严重冠状病毒疾病（Covid-19）肺炎患者成功治疗Lopinavir / Ritonavir Plus FaviPiravir：案例系列

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

The combination therapy of Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID‐19. Serum ferritin levels and lymphocytopenia are promising markers for disease severity and disease progression that are commonly available in general clinical practice.

机译：Lopinavir / Ritonavir Plus FaviPiravir的联合治疗可能是Covid-19患者的治疗选择。血清铁蛋白水平和淋巴细胞病是疾病严重程度和疾病进展的有希望的标志，普遍临床实践中常用。

著录项

期刊名称 Clinical Case Reports
作者
Hayato Koba; Taro Yoneda; Tomoya Kaneda; Tsukasa Ueda; Hideharu Kimura; Kazuo Kasahara;
展开▼
作者单位

展开▼
年(卷),期 2020(8),12
年度 2020
页码 3143–3148
总页数 6
原文格式 PDF
正文语种
中图分类
关键词
COVID‐19; favipiravir; ferritin; Lopinavir; lymphocytopenia; ritonavir;

机译：Covid-19;FEVIPIRAVIR;铁蛋白;Lopinavir;淋巴细胞病;Ritonavir;

相似文献

外文文献
中文文献
专利

1. Comparison of non-severe COVID-19 pneumonia patients treated with lopinavir/ritonavir and favipiravir [J] . Omer AYTEN, Bengü ?AYLAN Journal of surgery and medicine. . 2020,第11期

机译：非严重Covid-19肺炎治疗Lopinavir / Ritonavir和FaviPiravir的肺炎患者的比较
2. Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR [J] . Trends in Ecology & Evolution . 2020,第6期

机译：韩国冠状病毒疾病促成三级传播的指数患者：Lopinavir / Ritonavir对定量RT-PCR监测Covid-19肺炎治疗的应用
3. Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR [J] . Lim Jaegyun, Jeon Seunghyun, Shin Hyun-Young, Journal of Korean medical science. . 2020,第6期

机译：韩国冠状病毒疾病第三次传播的指数患者：Lopinavir / Ritonavir对定量RT-PCR监测Covid-19肺炎治疗的应用
4. 2019 Novel Coronavirus Disease (Covid-19): Toward a Novel Design for Disinfection Robot to Combat Coronavirus (Covid-19) Using IoT Based Technology [C] . M. N. Mohammed, Nurul Aslamiah Hazairin, Arif Sameh Arif, IEEE Control and System Graduate Research Colloquium . 2021

机译：2019年新型冠状病毒病（Covid-19）：朝着使用基于机器的技术的消毒机器人的新设计，用于打击冠状病毒（Covid-19）
5. The Effects of the Coronavirus Disease 2019 (COVID-19) on G7 Financial Markets [D] . Elatraby, Karim. 2021

机译：冠状病毒疾病2019（Covid-19）对G7金融市场的影响
6. Tocilizumab for treating severe COVID‐19 pneumonia refractory to combined hydroxychloroquine lopinavir plus ritonavir and favipiravir: A case series [O] . Manoon Surabotsophon, Yingyot Klai‐On, Vipa Thanachartwet, 2020

机译：用于治疗严重的Covid-19肺炎难以组合羟氯喹Lopinavir Plus Ritonavir和Favipiravir的难治性：案例系列
7. Tocilizumab for treating severe COVID‐19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series [O] . Manoon Surabotsophon, Yingyot Klai‐On, Vipa Thanachartwet, 2020

机译：用于治疗严重的Covid-19肺炎难以组合羟氯喹，Lopinavir Plus Ritonavir和Favipiravir的难治性：案例系列

Severe coronavirus disease 2019 (COVID‐19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅